GLOBEALERT

Feed

Open sources, classified and cross-checked. 7,537+ stories.

BUSINESSSep 16Heartland Express declares $0.02 dividendHeartland Express declared a $0.02 dividend, indicating a payout to its shareholders. This is a standard financial announcement from the company.Seeking Alpha Tech
BUSINESSSep 16Lineage declares $0.5325 dividendLineage has declared a $0.5325 dividend. This is a routine financial announcement from a company to its shareholders.Seeking Alpha Tech
BUSINESSSep 16Fulton Financial declares $0.19 dividendFulton Financial has declared a $0.19 dividend. This is a routine financial announcement from a company to its shareholders.Seeking Alpha Tech
BUSINESSSep 16Invesco Mortgage Capital declares $0.12 dividendInvesco Mortgage Capital has declared a $0.12 dividend. This is a routine financial announcement from a company to its shareholders.Seeking Alpha Tech
BUSINESSSep 16Spear Street’s Instinct in talks to raise $1B at $10B valuation: reportSpear Street's Instinct is reportedly in discussions to raise $1 billion, which would value the company at $10 billion. This indicates a significant development in the company's financial growth.Seeking Alpha Tech
BUSINESSSep 16Bond yields are spiking, oil is up — but investors aren’t giving up on stocksRising Treasury yields, geopolitical risk and fresh AI safety concerns are hitting markets, but many investors remain bullish on AI spending and earnings.CNBC
BUSINESSSep 16Brookfield to acquire Reliance Worldwide in all-cash $2.9B dealBrookfield is set to acquire Reliance Worldwide in a $2.9 billion all-cash transaction. This signifies a major corporate acquisition.Seeking Alpha Tech
BUSINESSSep 16Why is European money financing the American AI boom?Eurozone households have hundreds of billions of euros invested in US technology. Analysts say Europe has the money and promising companies, but too few become accessible investments for ordinary savers.EuroNews [en]
BUSINESSSep 16Treasury yields hitting 5% may not break markets now — but the clock is tickingThe 10-year Treasury yield hit its highest since 2007, pushing borrowing costs deeper into territory that could expose some of the financial system's weakest links.CNBC
BUSINESSSep 16Axon prices $1B offering of 0% convertible senior notes due 2031, adds capped callsAxon has priced a $1 billion offering of convertible senior notes due in 2031, along with capped calls. This indicates a corporate financing activity.Seeking Alpha Tech
BUSINESSSep 16World’s best-performing sovereign wealth fund expects equities pullbackNew Zealand’s superannuation fund grows 14% despite being underweight on US tech stocksFinancial Times
BUSINESSSep 16Asian markets advance ahead of Fed decisionAsian markets are advancing in anticipation of a decision from the US Federal Reserve, indicating investor sentiment regarding upcoming monetary policy.Seeking Alpha Tech
BUSINESSSep 16Oil falls as U.S. crude inventories reportedly rise, traders weigh Saudi pipeline closureThe pipeline has allowed the Saudis to shift oil exports to the Red Sea while the U.S. and Iran battle for control over Hormuz.CNBC
BUSINESSSep 16OpenAI considers new financing at $1.2T valuation, FT reportsOpenAI is reportedly considering new financing that would value the company at $1.2 trillion, according to the Financial Times.Seeking Alpha Tech
BUSINESSSep 16Wednesday’s Economic CalendarThe article provides information on Wednesday's economic calendar. This details scheduled economic events and data releases.Seeking Alpha Tech
BUSINESSSep 16Gold gains with Fed rate decision in spotlight - ReutersGold rises on easing dollar, oil as Fed rate verdict looms ReutersReuters World
BUSINESSSep 16GSK licenses Chinese firm’s cancer drug in US$750 million dealBritish pharmaceutical giant GSK has agreed to acquire a cancer drug from Chinese firm Chimagen Biosciences in a deal worth up to US$750 million, underscoring China’s emergence as a global player in biotechnology. GSK announced plans on Tuesday to buy full global rights to a “potential best-in-class” T-cell engager (TCE) from Chengdu-based Chimagen, targeting treatment for multiple myeloma, a type of blood cancer. TCEs work by binding T cells, a kind of white blood cell, directly to cancer...South China Morning Post
BUSINESSSep 16Stocks dive ahead of expected Fed interest rate hikeStocks stayed in the red on Tuesday ahead of the Federal Reserve's interest rate decision on Wednesday. CBS News contributor Javier David has a preview of the meeting.CBS News
BUSINESSSep 16Neither tariffs nor export controls will stop China’s industrial engineThe first “China shock” was fairly easy to understand. Beginning in the 1990s, cheap Chinese goods poured into global markets, displacing large parts of lower-end manufacturing across the world. Now, China shock 2.0 seems to be under way, with China taking the lead in electric vehicles (EVs), batteries, solar panels, semiconductors and other more technologically sophisticated industries. This is often perceived as a trade problem, with Chinese manufacturers producing too much, selling too...South China Morning Post
BUSINESSSep 16Dollar girded by bets on a US hiking cycle - ReutersDollar girded by bets on a US hiking cycle ReutersReuters World
BUSINESSSep 15U.S. crude oil tops $105 as Saudi Arabia said to cancel some European cargoesU.S. crude oil prices have exceeded $105 per barrel following reports that Saudi Arabia has canceled some oil shipments to Europe. This indicates potential shifts in global oil supply and pricing.Seeking Alpha Tech
BUSINESSSep 15Trip.com Non-GAAP EPADS of $1.07 beats by $0.22, revenue of $2.3B misses by $20MTrip.com reported non-GAAP earnings per American Depositary Share (EPADS) of $1.07, surpassing estimates by $0.22, but its $2.3 billion revenue fell short of projections by $20 million.Seeking Alpha Tech
BUSINESSSep 15Rock Tech Lithium upsizes private placement to C$6M with strategic backingRock Tech Lithium has increased its private placement to C$6 million, securing additional strategic investment.Seeking Alpha Tech
BUSINESSSep 15OpenAI weighs funding round at $1.2tn valuation before IPOSam Altman’s start-up could capitalise on demand for its technology after new model launchesFinancial Times